ENANTA PHARMACEUTICALS INC (ENTA)

Latest Insider Confidence Score

2026Q1

53.9
Bullish

Company insider confidence (by quarter)

2013Q1 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Shionogi & Co Ltd — 1,599,760 Mar 28, 2013
Saints Capital Granite, L.P. 10% Owner 1,425,708 Oct 16, 2013
Saints Capital Granite, LLC 10% Owner 1,425,708 Oct 16, 2013
Mrna - Holdings Llc 10% Owner 1,425,708 Oct 16, 2013
OBP (Adjunct) III - Holdings LLC 10% Owner 1,425,708 Oct 16, 2013

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 12, 2026 Feb 13, 2026 Kowalsky Matthew Paul Chief Legal Officer Sell 91.3 +3,591 100.00% ✗ $27.1K
Feb 12, 2026 Feb 13, 2026 Luu Brendan Chief Business Officer Sell 86.3 +3,305 8.62% ✗ $46.4K
Feb 12, 2026 Feb 13, 2026 Kieffer Tara Lynn Chief Product Strategy Officer Sell 91.3 +3,305 10.79% ✗ $46.4K
Feb 12, 2026 Feb 13, 2026 Rottinghaus Scott T. Chief Medical Officer Sell 91.3 +3,462 15.89% ✗ $48.6K
Feb 12, 2026 Feb 13, 2026 Or Yat Sun Chief Scientific Officer Sell 68.8 +3,462 0.93% ✗ $48.6K
Feb 12, 2026 Feb 13, 2026 Luly Jay R. CEO Sell 82.5 +13,845 1.61% ✗ $87.7K
Dec 5, 2025 Dec 5, 2025 Capps Kathleen S. Officer Sell 47.5 -323 -3.71% ✗ $4.6K
Dec 5, 2025 Dec 5, 2025 Trout Harry R. III Officer Sell 47.5 -542 -3.21% ✗ $7.7K
Dec 5, 2025 Dec 5, 2025 Rottinghaus Scott T. Chief Medical Officer Sell 46.3 -798 -3.53% ✗ $11.4K
Dec 5, 2025 Dec 5, 2025 Luu Brendan Chief Business Officer Sell 46.3 -1,394 -3.51% ✗ $19.8K
Dec 5, 2025 Dec 5, 2025 Kieffer Tara Lynn Chief Product Strategy Officer Sell 46.3 -2,106 -6.44% ✗ $30K
Dec 5, 2025 Dec 5, 2025 Or Yat Sun Chief Scientific Officer Sell 48.8 -2,390 -0.64% ✗ $34K
Dec 5, 2025 Dec 5, 2025 Luly Jay R. CEO Sell 45.0 -4,743 -0.55% ✗ $67.5K
Dec 1, 2025 Dec 3, 2025 Capps Kathleen S. Officer Sell 47.5 -292 -3.25% ✗ $4.1K
Dec 1, 2025 Dec 3, 2025 Trout Harry R. III Officer Sell 47.5 -485 -2.79% ✗ $6.8K
Dec 1, 2025 Dec 3, 2025 Luu Brendan Chief Business Officer Sell 47.5 -498 -1.24% ✗ $7K
Dec 1, 2025 Dec 3, 2025 Kieffer Tara Lynn Chief Product Strategy Officer Sell 46.3 -753 -2.25% ✗ $10.6K
Dec 1, 2025 Dec 3, 2025 Or Yat Sun Chief Scientific Officer Sell 51.3 -753 -0.20% ✗ $10.6K
Dec 1, 2025 Dec 3, 2025 Luly Jay R. CEO Sell 51.3 -1,885 -0.22% ✗ $26.6K
Nov 25, 2025 Nov 26, 2025 Capps Kathleen S. Officer Neutral 90.0 +3,163 54.26% ✗ -
Nov 25, 2025 Nov 26, 2025 Trout Harry R. III Officer Neutral 90.0 +6,463 59.23% ✗ -
Nov 25, 2025 Nov 26, 2025 Luu Brendan Chief Business Officer Neutral 52.5 - 0.00% ✗ -
Nov 25, 2025 Nov 26, 2025 Kieffer Tara Lynn Chief Product Strategy Officer Neutral 52.5 - 0.00% ✗ -
Nov 25, 2025 Nov 26, 2025 Kowalsky Matthew Paul Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Nov 25, 2025 Nov 26, 2025 Rottinghaus Scott T. Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Nov 25, 2025 Nov 26, 2025 Or Yat Sun Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Nov 25, 2025 Nov 26, 2025 Luly Jay R. CEO Neutral 52.5 - 0.00% ✗ -
Sep 8, 2025 Capps Kathleen S. Officer Neutral 52.5 - 0.00% ✗ -
Sep 8, 2025 Trout Harry R. III President Neutral 52.5 - 0.00% ✗ -
Aug 8, 2025 Aug 8, 2025 Rottinghaus Scott T. Chief Medical Officer Sell 46.3 -2,217 -8.94% ✗ $15.5K
Mar 13, 2025 Mar 14, 2025 Vance Terry Director Neutral 52.5 - 0.00% ✗ -
Mar 13, 2025 Mar 14, 2025 Russell Lesley Director Neutral 52.5 - 0.00% ✗ -
Mar 13, 2025 Mar 14, 2025 Peterson Kristine Director Neutral 52.5 - 0.00% ✗ -
Mar 13, 2025 Mar 14, 2025 Hata Yujiro S Director Neutral 52.5 - 0.00% ✗ -
Mar 13, 2025 Mar 14, 2025 FOLETTA MARK G Director Neutral 52.5 - 0.00% ✗ -
Mar 13, 2025 Mar 14, 2025 CARTER BRUCE L A Director Neutral 52.5 - 0.00% ✗ -
Feb 12, 2025 Feb 14, 2025 Luu Brendan Chief Business Officer Sell 91.3 +4,174 11.58% ✗ $18.6K
Feb 12, 2025 Feb 14, 2025 Kieffer Tara Lynn Chief Product Strategy Officer Sell 91.3 +4,174 14.24% ✗ $18.6K
Feb 12, 2025 Feb 14, 2025 Rottinghaus Scott T. Chief Medical Officer Sell 91.3 +6,889 38.45% ✗ $16K
Feb 12, 2025 Feb 14, 2025 Or Yat Sun Chief Scientific Officer Sell 78.8 +5,426 1.47% ✗ $24.2K
Feb 12, 2025 Feb 14, 2025 MELLETT PAUL J Chief Fin. & Admin Officer Sell 83.8 +4,174 4.55% ✗ $18.6K
Feb 12, 2025 Feb 14, 2025 Luly Jay R. CEO Sell 78.8 +18,016 2.13% ✗ $41.8K
Feb 12, 2025 Feb 12, 2025 Luly Jay R. CEO Buy 92.5 +45,000 5.61% ✗ $256.1K
Dec 6, 2024 Dec 10, 2024 Kieffer Tara Lynn Chief Product Strategy Officer Sell 46.3 -2,283 -7.23% ✗ $18.4K
Dec 6, 2024 Dec 10, 2024 Luu Brendan Chief Business Officer Sell 46.3 -2,283 -5.96% ✗ $18.4K
Dec 6, 2024 Dec 10, 2024 Rottinghaus Scott T. Chief Medical Officer Sell 47.5 -866 -4.61% ✗ $7K
Dec 6, 2024 Dec 10, 2024 Or Yat Sun Chief Scientific Officer Sell 48.8 -2,591 -0.70% ✗ $20.9K
Dec 6, 2024 Dec 10, 2024 MELLETT PAUL J Chief Fin. & Admin Officer Sell 46.3 -2,591 -2.75% ✗ $20.9K
Dec 6, 2024 Dec 10, 2024 Luly Jay R. CEO Sell 48.8 -5,142 -0.64% ✗ $41.4K
Dec 1, 2024 Dec 3, 2024 Luu Brendan Chief Business Officer Sell 47.5 -753 -1.93% ✗ $6.5K
Dec 1, 2024 Dec 3, 2024 Kieffer Tara Lynn Chief Product Strategy Officer Sell 47.5 -753 -2.33% ✗ $6.5K
Dec 1, 2024 Dec 3, 2024 Or Yat Sun Chief Scientific Officer Sell 51.3 -1,595 -0.43% ✗ $13.7K
Dec 1, 2024 Dec 3, 2024 MELLETT PAUL J Chief Fin. & Admin Officer Sell 46.3 -1,595 -1.66% ✗ $13.7K
Dec 1, 2024 Dec 3, 2024 Luly Jay R. CEO Sell 51.3 -3,829 -0.47% ✗ $32.9K
Nov 27, 2024 Nov 27, 2024 Kowalsky Matthew Paul Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Nov 27, 2024 Nov 27, 2024 Luu Brendan Chief Business Officer Neutral 52.5 - 0.00% ✗ -
Nov 27, 2024 Nov 27, 2024 Kieffer Tara Lynn Chief Product Strategy Officer Neutral 52.5 - 0.00% ✗ -
Nov 27, 2024 Nov 27, 2024 Rottinghaus Scott T. Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Nov 27, 2024 Nov 27, 2024 Or Yat Sun Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Nov 27, 2024 Nov 27, 2024 MELLETT PAUL J Chief Fin. & Admin Officer Neutral 52.5 - 0.00% ✗ -
Nov 27, 2024 Nov 27, 2024 Luly Jay R. CEO Neutral 52.5 - 0.00% ✗ -
Aug 8, 2023 Aug 9, 2024 Rottinghaus Scott T. Chief Medical Officer Sell 46.3 -2,933 -6.21% ✗ $43.9K
Jul 11, 2024 Jul 15, 2024 Rottinghaus Scott T. Chief Medical Officer Sell 20.0 -11,945 -15.05% ✓ $190.7K
Jun 17, 2024 Jun 17, 2024 Kieffer Tara Lynn Chief Product Strategy Officer Sell 20.0 -7,266 -18.35% ✓ $89.6K
Apr 29, 2024 May 1, 2024 Kowalsky Matthew Paul Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
May 1, 2024 Kowalsky Matthew Paul Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Mar 6, 2024 Mar 8, 2024 Vance Terry Director Neutral 52.5 - 0.00% ✗ -
Mar 6, 2024 Mar 8, 2024 Russell Lesley Director Neutral 52.5 - 0.00% ✗ -
Mar 6, 2024 Mar 8, 2024 Peterson Kristine Director Neutral 52.5 - 0.00% ✗ -
Mar 6, 2024 Mar 8, 2024 Hata Yujiro S Director Neutral 52.5 - 0.00% ✗ -
Mar 6, 2024 Mar 8, 2024 FOLETTA MARK G Director Neutral 52.5 - 0.00% ✗ -
Mar 6, 2024 Mar 8, 2024 CARTER BRUCE L A Director Neutral 52.5 - 0.00% ✗ -
Feb 26, 2024 Feb 27, 2024 Gardiner Nathaniel S. Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Feb 12, 2024 Feb 14, 2024 Luu Brendan Chief Business Officer Sell 86.3 +2,347 6.39% ✗ $12.1K
Feb 12, 2024 Feb 14, 2024 Kieffer Tara Lynn Chief Product Strategy Officer Sell 86.3 +2,347 6.30% ✗ $12.1K
Feb 12, 2024 Feb 14, 2024 Gardiner Nathaniel S. Chief Legal Officer Sell 78.8 +2,347 2.25% ✗ $12.1K
Feb 12, 2024 Feb 14, 2024 Rottinghaus Scott T. Chief Medical Officer Sell 85.0 +1,821 6.88% ✗ $9.4K
Feb 12, 2024 Feb 14, 2024 Or Yat Sun Chief Scientific Officer Sell 68.8 +2,600 0.70% ✗ $13.4K
Feb 12, 2024 Feb 14, 2024 MELLETT PAUL J Chief Fin. & Admin Officer Sell 83.8 +2,347 2.51% ✗ $12.1K
Feb 12, 2024 Feb 14, 2024 Luly Jay R. CEO Sell 61.3 +3,816 0.47% ✗ $19.7K
Dec 13, 2023 Dec 15, 2023 Vance Terry Director Sell 22.5 -15,295 -72.51% ✗ $139.5K
Dec 5, 2023 Dec 6, 2023 Luu Brendan Sr. VP, Business Dev. Sell 46.3 -2,125 -5.47% ✗ $20.5K
Dec 5, 2023 Dec 6, 2023 Kieffer Tara Lynn Sr. VP, New Prod. Strat. & Dev Sell 46.3 -2,125 -5.40% ✗ $20.5K
Dec 5, 2023 Dec 6, 2023 Gardiner Nathaniel S. Sr. VP & General Counsel Sell 46.3 -2,412 -2.26% ✗ $23.2K
Dec 5, 2023 Dec 6, 2023 Rottinghaus Scott T. Sr. VP & CMO Sell 47.5 -534 -1.98% ✗ $5.1K
Dec 5, 2023 Dec 6, 2023 Or Yat Sun Sr. VP, R&D & CSO Sell 48.8 -2,412 -0.65% ✗ $23.2K
Dec 5, 2023 Dec 6, 2023 MELLETT PAUL J CFO Sell 46.3 -2,412 -2.51% ✗ $23.2K
Dec 5, 2023 Dec 6, 2023 Luly Jay R. CEO Sell 45.0 -7,230 -0.89% ✗ $69.6K
Dec 1, 2023 Dec 5, 2023 Luu Brendan Sr. VP, Business Dev. Sell 47.5 -753 -1.90% ✗ $7.1K
Dec 1, 2023 Dec 5, 2023 Kieffer Tara Lynn Sr. VP, New Prod. Strat. & Dev Sell 47.5 -753 -1.88% ✗ $7.1K
Dec 1, 2023 Dec 5, 2023 Gardiner Nathaniel S. Sr. VP & General Counsel Sell 46.3 -1,595 -1.48% ✗ $15.1K
Dec 1, 2023 Dec 5, 2023 Or Yat Sun Sr. VP, R&D & CSO Sell 51.3 -1,595 -0.43% ✗ $15.1K
Dec 1, 2023 Dec 5, 2023 MELLETT PAUL J CFO Sell 46.3 -1,595 -1.63% ✗ $15.1K
Dec 1, 2023 Dec 5, 2023 Luly Jay R. CEO Sell 45.0 -5,787 -0.71% ✗ $54.9K
Nov 22, 2023 Nov 22, 2023 Luu Brendan Sr. VP, Business Dev. Neutral 52.5 - 0.00% ✗ -
Nov 22, 2023 Nov 22, 2023 Kieffer Tara Lynn Sr. VP, New Prod. Strat. & Dev Neutral 52.5 - 0.00% ✗ -
Nov 22, 2023 Nov 22, 2023 MELLETT PAUL J CFO Neutral 52.5 - 0.00% ✗ -
Nov 22, 2023 Nov 22, 2023 Gardiner Nathaniel S. Sr. VP & General Counsel Neutral 52.5 - 0.00% ✗ -
Nov 22, 2023 Nov 22, 2023 Or Yat Sun Sr. VP, R&D & CSO Neutral 52.5 - 0.00% ✗ -
Nov 22, 2023 Nov 22, 2023 Rottinghaus Scott T. Sr. VP & CMO Neutral 52.5 - 0.00% ✗ -